Identifying COVID‐19 subtypes by single‐sample gene set enrichemnt analysis and providing guidance for sensitive drug selection

Documenti analoghi

• Correction to “Exploring the impact of ursodeoxycholic acid therapy on COVID‐19 in a real‐word setting”
  Pubblicazione: (2024)
• Study on the epidemiological characteristics of enterovirus among pediatric patients in Hangzhou, China: A comparison between the pre‐COVID‐19, COVID‐19 pandemic, and post‐COVID‐19 periods
  di: Yanhong Sun, et al.
  Pubblicazione: (2024)
• A Clinical Investigation Into the Effects of Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Vaccination in Children With Acute Lymphoblastic Leukemia
  di: Zhengcun Wu, et al.
  Pubblicazione: (2025)
• Identifying Neurological Autoantibodies in COVID‐19: mGluR2 as a Marker of Immune Dysregulation During the Omicron Outbreak in China
  di: Ziyan Wu, et al.
  Pubblicazione: (2025)
• Impact of Nonpharmaceutical Interventions During the COVID‐19 Pandemic on the Epidemiology and Seasonal Patterns of Acute Respiratory Infections in Children
  di: Shiwei Zheng, et al.
  Pubblicazione: (2025)